Byhealth Co., Ltd (SHE:300146)

Market Cap	17.59B -10.7%
Revenue (ttm)	6.34B +6.0%
Net Income	729.32M +91.5%
EPS	0.44 +97.8%
Shares Out	1.68B
PE Ratio	23.92
Forward PE	21.52
Dividend	0.45 (4.29%)
Ex-Dividend Date	Apr 21, 2026

Volume	11,325,162
Average Volume	12,730,512
Open	10.70
Previous Close	10.55
Day's Range	10.47 - 10.70
52-Week Range	10.35 - 13.20
Beta	0.49
RSI	36.33
Earnings Date	Apr 25, 2026

About Byhealth

Byhealth Co., Ltd, together with its subsidiaries, provides dietary supplements in China, Hong Kong, Australia, and internationally. It offers protein powder; collagen; bone health products, including glucosamine, chondroitin, and calcium tablets; probiotics; capsules; and multivitamins under the By-Health, Jianlidu, LifeSpace, and other brand names. The company also engages in scenic area tourism management; real estate; trade and investment; sale of food; trademark management; and OTC licensing and outsourced processing activities. It sells i...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1995
• Employees: 2,867
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300146

Financial Performance

In 2025, Byhealth's revenue was 6.27 billion, a decrease of -8.38% compared to the previous year's 6.84 billion. Earnings were 782.15 million, an increase of 19.81%.